104 related articles for article (PubMed ID: 3494841)
1. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
Spearman ME; Goodwin RM; Apelgren LD; Bumol TF
J Pharmacol Exp Ther; 1987 May; 241(2):695-703. PubMed ID: 3494841
[TBL] [Abstract][Full Text] [Related]
2. Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
Spearman ME; Goodwin RM; Kau D
Drug Metab Dispos; 1987; 15(5):640-7. PubMed ID: 2891480
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the monoclonal antibody-Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer.
Apelgren LD; Zimmerman DL; Briggs SL; Bumol TF
Cancer Res; 1990 Jun; 50(12):3540-4. PubMed ID: 2340502
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
Lindstrom TD; Althaus WA; Ruterbories KJ; Kau D
J Pharmacol Exp Ther; 1990 Mar; 252(3):1117-24. PubMed ID: 2319463
[TBL] [Abstract][Full Text] [Related]
5. Disposition of a murine monoclonal antibody vinca conjugate (KS1/4-DAVLB) in patients with adenocarcinomas.
Schneck D; Butler F; Dugan W; Littrell D; Petersen B; Bowsher R; DeLong A; Dorrbecker S
Clin Pharmacol Ther; 1990 Jan; 47(1):36-41. PubMed ID: 2295217
[TBL] [Abstract][Full Text] [Related]
6. The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studies.
Petersen BH; DeHerdt SV; Schneck DW; Bumol TF
Cancer Res; 1991 May; 51(9):2286-90. PubMed ID: 2015593
[TBL] [Abstract][Full Text] [Related]
7. In vivo selection of human tumor cells resistant to monoclonal antibody-Vinca alkaloid immunoconjugates.
Starling JJ; Maciak RS; Hinson NA; Hoskins J; Laguzza BC; Gadski RA; Strnad J; Rittmann-Grauer L; DeHerdt SV; Bumol TF
Cancer Res; 1990 Dec; 50(23):7634-40. PubMed ID: 1979247
[TBL] [Abstract][Full Text] [Related]
8. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
[No Abstract] [Full Text] [Related]
9. Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27.
Schrappe M; Bumol TF; Apelgren LD; Briggs SL; Koppel GA; Markowitz DD; Mueller BM; Reisfeld RA
Cancer Res; 1992 Jul; 52(14):3838-44. PubMed ID: 1617657
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs.
Apelgren LD; Bailey DL; Briggs SL; Barton RL; Guttman-Carlisle D; Koppel GA; Nichols CL; Scott WL; Lindstrom TD; Baker AL
Bioconjug Chem; 1993; 4(2):121-6. PubMed ID: 7873643
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes.
Starling JJ; Maciak RS; Law KL; Hinson NA; Briggs SL; Laguzza BC; Johnson DA
Cancer Res; 1991 Jun; 51(11):2965-72. PubMed ID: 2032233
[TBL] [Abstract][Full Text] [Related]
12. New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity.
Laguzza BC; Nichols CL; Briggs SL; Cullinan GJ; Johnson DA; Starling JJ; Baker AL; Bumol TF; Corvalan JR
J Med Chem; 1989 Mar; 32(3):548-55. PubMed ID: 2783975
[TBL] [Abstract][Full Text] [Related]
13. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
Sung C; Youle RJ; Dedrick RL
Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
[TBL] [Abstract][Full Text] [Related]
15. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
Stastny JJ; Das Gupta TK
Cancer Res; 1993 Dec; 53(23):5740-4. PubMed ID: 8242630
[TBL] [Abstract][Full Text] [Related]
16. Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
Meyer DL; Jungheim LN; Law KL; Mikolajczyk SD; Shepherd TA; Mackensen DG; Briggs SL; Starling JJ
Cancer Res; 1993 Sep; 53(17):3956-63. PubMed ID: 8358723
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.
Jiang FN; Richter AM; Jain AK; Levy JG; Smits C
Biotechnol Ther; 1993; 4(1-2):43-61. PubMed ID: 8374512
[TBL] [Abstract][Full Text] [Related]
18. Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.
Johnson DA; Laguzza BC
Cancer Res; 1987 Jun; 47(12):3118-22. PubMed ID: 3495327
[TBL] [Abstract][Full Text] [Related]
19. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of L/1C2-4-desacetylvinblastine-3-carboxhydrazide immunoconjugate in xenografts.
Johnson DA; Baker AL; Laguzza BC; Fix DV; Gutowski MC
Cancer Res; 1990 Mar; 50(6):1790-4. PubMed ID: 2306731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
